1. Home
  2. Business Services

Category: Pharma and Healthcare

ArchiMed reaps 4x on Bomi sale to UPS

Specialist investor ArchiMed has sold Italy-based healthcare logistics platform Bomi to US-listed parcel shipping group UPS, earning a 4x money return.

ArchiMed seals 4x return selling Bomi Group to UPS – source

Healthcare-focused buyout house ArchiMed has scored a 4x return selling Italian healthcare logistics provider Bomi Group to UPS, AltAssets has learned. The post ArchiMed seals 4x return selling Bomi Group to UPS – source first appeared

GP Profile: Greenpeak Partners on emerging manager fundraising and specialisation

As Greenpeak Partners wraps up the final close of its second fund, managing partner Daniel Beringer speaks to Unquote about the Munich-headquartered GP’s latest fundraise and its focus on healthcare, business and real assets services

Gilde Equity exits Avinty to Main Capital

Gilde Equity Management has sold its majority stake in Dutch healthcare software developer Avinty to Main Capital Partners.

AlpInvest-backed healthcare investor Assured hits $750m fund close

Assured Healthcare Partners, the specialist investor backed by Carlyle arm AlpInvest, has struck a $750m-plus fund close. The post AlpInvest-backed healthcare investor Assured hits $750m fund close first appeared on AltAssets Private Equity News.

Montagu to exit Arkopharma for EUR 450m

Private equity firm Montagu entered into exclusive negotiations to sell French health supplement maker Arkopharma to branded drug manufacturer Dermapharm for EUR 450m.

Havencrest adds Alek Blankenau as principal following Fund II close

Healthcare-focused buyout house Havencrest Capital Management has hired Alek G. Blankenau from fellow Latticework Capital Management as principal. The post Havencrest adds Alek Blankenau as principal following Fund II close first appeared on AltAssets Private

Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA

San Diego, California and London, UK, 25 July 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced its launch with $55 million in seed financing. The round

Global M&A Industry Trends: 2022 Mid-Year Update

Posted by Malcolm Lloyd, Colin Wittmer, and John Potter, PricewaterhouseCoopers LLP, on Monday, July 25, 2022 Editor's Note: Malcolm Lloyd is Deals Leader, PwC Global and EMEA; Colin Wittmer is Deals Leader, PwC US; and

SHS nears EUR 250m hard cap on sixth fund

SHS Gesellschaft, a German specialist healthcare investor, has held a EUR 220m first close on its sixth fund, just EUR 30m shy of the fund’s hard cap.

Five Arrows exits pharmacy group Laf Sante to Latour

Five Arrows has sold Hygie31, a France-based pharmacy chain that includes low-cost brand Laf Sante, to Latour Capital in an auction preempted by the French sponsor.

Nashville’s Resolute beats target for fifth flagship fund targeting business, healthcare services

Business and healthcare services-focused private equity investor Resolute Capital Partners has hit a target-beating $405m final close for its fifth flagship fund. The post Nashville’s Resolute beats target for fifth flagship fund targeting business, healthcare

Forbion exceeds Growth Opportunities II target with EUR 470m first close

Dutch biopharma investor Forbion has held the first close for Forbion Growth Opportunities II at EUR 470m; the fund will invest in late-stage biopharma companies at a time when they need private capital, the GP

Thomas H Lee Partners boosts healthcare team with second senior hire in nine months

Mid-market investor Thomas H Lee Partners has hired healthcare industry veteran Sam Hendler to head business development. The post Thomas H Lee Partners boosts healthcare team with second senior hire in nine months first appeared

EQT, Mubadala to acquire Envirotainer for EUR 2.8bn

EQT and Abu Dhabi-based Mubadala have agreed to buy a majority investment in Envirotainer, a Swedish temperature-controlled distributor of biopharmaceuticals, from Cinven and Novo Holdings for EUR 2.8bn.

Graphite Capital exits Random42 in trade sale

Graphite Capital has sold its stake in Random42, a leading medical animation studio, to US-based medical communications agency Lockwood Group.

Blackstone near deal to buy Advarra from Genstar at $5bn valuation – report

Private equity giant Blackstone is said to be nearing a deal to buy pharmaceuticals and regulatory consulting business Advarra from Genstar Capital at $5bn valuation. The post Blackstone near deal to buy Advarra from Genstar

Astorg buys Open Health in SBO from Amulet

Astorg has acquired British medical communications company Open Health from American GP Amulet Capital.

Astorg to acquire pharmaceutical communications provider OPEN Health from Amulet

French private equity group Astorg has agreed to acquire pharmaceutical communications provider OPEN Health from healthcare-focused buyout house Amulet Capital Partners. The post Astorg to acquire pharmaceutical communications provider OPEN Health from Amulet first appeared on

FlexPoint Ford brings in IR veteran Stein as head of investor relations

Financial services and healthcare-focused private equity house Flexpoint Ford has hired Meredith Stein as head of investor relations. The post FlexPoint Ford brings in IR veteran Stein as head of investor relations first appeared on AltAssets

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.